Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor

This publication has 13 references indexed in Scilit:

• Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV
  Antiviral Research, 1995
• Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
  Journal of Clinical Investigation, 1995
• Design, Synthesis, and Biological Evaluation of Cosalane, a Novel Anti-HIV Agent Which Inhibits Multiple Features of Virus Reproduction
  Journal of Medicinal Chemistry, 1994
• Tryptase TL₂ in the membrane of human T4⁺ lymphocytes is a novel binding protein of the V3 domain of HIV‐1 envelope glycoprotein gp120
  FEBS Letters, 1991
• In Vitro Inhibition of HIV-1 Infectivity by Human Salivas
  AIDS Research and Human Retroviruses, 1990
• Regulation of Proteolysis at the Neutrophil-Substrate Interface by Secretory Leukoprotease Inhibitor
  Science, 1990
• Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children
  The Journal of the American Dental Association, 1989
• Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infection
  FEBS Letters, 1989
• Saliva inhibits HIV-1 infectivity
  The Journal of the American Dental Association, 1988
• In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen.
  The Journal of Experimental Medicine, 1982